Date : Thursday October 23rd, 2014
Time : 7:15 – 8:15 am
Location : Sheraton Denver Downtown Hotel, Plaza E room, 1550 Court Place, Denver, CO, USA 80202
Fee : This event is open and free to all participants attending ASHI 2014 (Doctors, Scientists, Nurses, Allied Health Professionals, Coordinators, Technicians, etc.)

Overview :

The TTS Women in Transplantation initiative has been set up to provide support and guidance to future generations of transplant professionals. Our Networking Events are an interesting and unique opportunity for women to make contact with others in the same field.

"Being Right is Not Enough – It’s How the Message is Delivered"

Guest Speaker: Mary Sue LefellMARY SUE LEFFELL, PhD, D.ABMLI, D.ABHI

Mary S. (Susie) Leffell, Ph.D., is Professor of Medicine and Director of the Immunogenetics and Transplantation Immunology Division of the Johns Hopkins University School of Medicine. She has been active in clinical transplantation for over thirty years. Her research interests have included population studies of the distribution of HLA alleles and haplotypes, minor histocompatibility antigens, KIR, and cytokine alleles among various racial/ethnic groups. In transplantation immunology, she has studied the impact of inflammation and infection among sensitized solid organ transplant candidates, as well as post-transplant sensitization following mismatched allogeneic hematopoietic cell transplantation (HCT), and more recently, helped establish a successful protocol for desensitization of HCT candidates with donor HLA-specific antibodies.  She is a past president of ASHI and a past chair of the Accreditation Program.  Her contributions to the OPTN/UNOS include service on the Board of Directors for two terms and on several committees, including the Kidney Allocation Review Sub-committee and as chair of the Histocompatibility Committee.  As a consultant to the FDA Center for Biologics Evaluation and Research, she served on the Blood Products Advisory Committee and the Advisory Committee on Clinical Practices in HLA testing for organ transplantation. She has been a member of the Advisory Committee on Organ Transplantation to the Secretary of the Department of Health and Human Services and is currently a member of the International Histocompatibility and Immunogenetics Council.  In 2011, she was honored with the Distinguished Scientist Award from the ASHI.


Elaine-Reed 2ELAINE REED, PhD

Dr. Elaine F. Reed is Professor of Pathology at the University of California, Los Angeles and Director of the UCLA Immunogenetics Center.  She directs the research and clinical activities of the UCLA Immunogenetics Center and serves as Vice Chair of Research Services for the Department of Pathology. Dr. Reed’s research interests over the last 26 years have focused on mechanisms of antibody-mediated acute and chronic allograft rejection. Her recent research studies demonstrated that anti-HLA antibodies can contribute to the development of chronic rejection by triggering intracellular signaling cascades that culminate in endothelial cell and smooth muscle cell survival and proliferation. Her work has delineated the signaling pathways leading to cell proliferation and cell survival, providing the opportunity for the development of therapeutic strategies. Dr. Reed is an active member of the American Society for Histocompatibility and Immunogenetics, American Association of Immunologists, American Society of Transplantation, Federation of Clinical Immunology Societies, International Society for Heart and Lung Transplantation, and The Transplantation Society. She serves on the editorial boards of Human Immunology, American Journal of Transplantation and Transplant Immunology.